Andrew Megerian

Andrew Megerian is a Senior Analyst at Freestone Grove Partners, based in New York, NY. In this role, he conducts in-depth fundamental research and investment analysis, contributing to portfolio construction and idea generation across key equity sectors. His current focus at Freestone Grove Partners is within public equities, where he evaluates company financials, industry trends, and market dynamics to identify investment opportunities.

Previously, Andrew served as a Research Analyst at Point72, where he was responsible for sector-specific equity research, covering industries such as technology, consumer, and healthcare from 2020 through 2024. He began his career as an Associate Equity Analyst at Rockefeller Capital Management, supporting senior analysts with research, modeling, and client communications within U.S. equities.

Andrew holds a Bachelor of Arts in Economics from Yale University, underpinning his expertise in quantitative analysis and market evaluation. He is recognized for his rigorous research approach and his ability to generate differentiated investment insights across several sectors, including technology and consumer discretionary. His analytical contributions to investment teams have supported successful capital allocation and risk management decisions throughout his career.